Aligned Genetics, Inc. (KOSDAQ: 238120)

Aligned Genetics Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	14,933	15,215	13,753	11,762	7,957	7,794
Other Revenue	-0	-0	-0	-	-	-
Revenue	14,933	15,215	13,753	11,762	7,957	7,794
Revenue Growth (YoY)	6.12%	10.63%	16.92%	47.82%	2.10%	37.33%
Cost of Revenue	4,324	4,556	4,998	4,424	3,425	3,193
Gross Profit	10,609	10,659	8,755	7,338	4,532	4,601
Selling, General & Admin	5,194	5,125	4,287	3,791	3,446	3,637
Research & Development	2,067	1,684	1,079	943.58	816.17	884.8
Other Operating Expenses	91.97	84.21	77.31	59.34	35.92	20.5
Operating Expenses	7,749	7,322	5,906	5,159	4,785	4,999
Operating Income	2,859	3,337	2,849	2,179	-253.48	-398.92
Interest Expense	-216.87	-214.88	-165.96	-28.88	-82.83	-96.84
Interest & Investment Income	479.71	161.61	168.16	27.71	163.3	119.88
Earnings From Equity Investments	90.95	-	-	-	-79.28	-
Currency Exchange Gain (Loss)	762.88	302.06	17.89	353.05	-255.15	86.89
Other Non Operating Income (Expenses)	4.29	8.09	83.88	-238.9	31.32	8.58
EBT Excluding Unusual Items	3,980	3,594	2,953	2,292	-476.12	-280.41
Gain (Loss) on Sale of Investments	-147.75	-147.75	-510.71	1,507	944.36	349.38
Gain (Loss) on Sale of Assets	-22.04	-22.04	-	13.94	-	47.76
Pretax Income	3,811	3,424	2,442	3,813	468.23	116.74
Income Tax Expense	495.8	188.16	109.5	-1,729	-	-
Net Income	3,315	3,236	2,333	5,542	468.23	116.74
Net Income to Common	3,315	3,236	2,333	5,542	468.23	116.74
Net Income Growth	51.52%	38.72%	-57.91%	1083.52%	301.10%	-
Shares Outstanding (Basic)	14	14	14	14	10	14
Shares Outstanding (Diluted)	14	14	14	14	10	14
Shares Change (YoY)	-	-	-	38.26%	-27.67%	-
EPS (Basic)	230.54	225.05	162.23	385.40	45.02	8.12
EPS (Diluted)	230.50	225.00	162.00	385.40	45.00	8.00
EPS Growth	51.64%	38.89%	-57.97%	756.45%	462.50%	-
Free Cash Flow	2,055	1,970	220.98	-3,171	-60.76	397.66
Free Cash Flow Per Share	142.91	137.01	15.37	-220.57	-5.84	27.66
Gross Margin	71.05%	70.06%	63.66%	62.38%	56.95%	59.03%
Operating Margin	19.15%	21.93%	20.72%	18.53%	-3.19%	-5.12%
Profit Margin	22.20%	21.27%	16.96%	47.12%	5.88%	1.50%
Free Cash Flow Margin	13.76%	12.95%	1.61%	-26.96%	-0.76%	5.10%
EBITDA	3,470	3,968	3,499	2,718	422.59	317.44
EBITDA Margin	23.24%	26.08%	25.45%	23.10%	5.31%	4.07%
D&A For EBITDA	610.37	631.38	650.38	538.59	676.07	716.36
EBIT	2,859	3,337	2,849	2,179	-253.48	-398.92
EBIT Margin	19.15%	21.93%	20.72%	18.53%	-3.19%	-5.12%
Effective Tax Rate	13.01%	5.50%	4.48%	-	-	-
Advertising Expenses	-	261.67	243.86	96.94	229.45	308.51

Source: S&P Capital IQ. Standard template. Financial Sources.